# Purple Coneflower (Echinacea purpurea)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/purple-coneflower
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 8 / 10
**Category:** Native American
**Also Known As:** Echinacea purpurea, Eastern Purple Coneflower, Purple Echinacea, American Coneflower, Hedgehog Coneflower, Black Sampson, Red Sunflower, Snakeroot

## Overview

Echinacea purpurea is a flowering plant containing bioactive compounds like alkylamides and polyphenols that modulate [immune function](/ingredients/condition/immune-support). Clinical studies demonstrate it can reduce the incidence of upper respiratory infections by 19% and shorten infection duration in children.

## Health Benefits

• May reduce the incidence of upper respiratory tract infections by 19% when used preventively (Moderate evidence from meta-analysis of 9 RCTs)
• Significantly shortens the duration of respiratory infections in children (Moderate evidence from meta-analysis, SMD = -0.19)
• Reduces antibiotic usage for respiratory infections by 82% in children (Moderate evidence from meta-analysis, RR = 0.18)
• Shows comparable safety profile to placebo in long-term use over 4 months (Strong evidence from large RCT with 717 subjects)
• Demonstrates cellular immunostimulation effects, though clinical significance remains unclear (Limited evidence)

## Mechanism of Action

Echinacea's alkylamides and phenolic compounds activate macrophages and enhance natural killer cell activity through modulation of [cytokine](/ingredients/condition/inflammation) production. The compounds stimulate phagocytosis and increase production of interferon-α, interleukin-1β, and tumor necrosis factor-α. Polysaccharides in echinacea bind to complement receptors and activate the alternative complement pathway.

## Clinical Summary

A meta-analysis of 9 randomized controlled trials found preventive echinacea use reduced upper respiratory tract infection incidence by 19%. Another systematic review demonstrated significant reduction in infection duration in children (SMD = -0.19). Studies show reduced antibiotic usage when echinacea is used for respiratory infections. Most trials used standardized extracts containing 4% phenolics for 8-12 weeks.

## Nutritional Profile

Purple Coneflower (Echinacea purpurea) is not consumed as a food for macronutrient value; it is used primarily as a medicinal herb. Its therapeutic profile is defined by its bioactive phytochemical constituents rather than caloric or macronutrient content. Key bioactive compounds include: • **Alkamides (Alkylamides):** ~0.01–0.04% in dried root, ~0.001–0.01% in aerial parts; the most bioavailable [immunomodulatory](/ingredients/condition/immune-support) compounds, rapidly absorbed through oral mucosa and GI tract with high oral bioavailability (~50–75%); key compounds include dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides. • **Caffeic acid derivatives:** Cichoric acid (dicaffeoyltartaric acid) is the dominant phenolic, present at ~1.2–3.1% of dry weight in aerial parts and ~0.6–2.1% in roots; echinacoside (caffeic acid glycoside) at ~0.3–1.3% in roots (more abundant in E. angustifolia); caftaric acid at ~0.1–0.8%; chlorogenic acid at ~0.02–0.1%. Bioavailability of cichoric acid is moderate but subject to rapid enzymatic degradation. • **Polysaccharides:** Arabinogalactans and heteroxylans at ~1–4% of dry root weight; fucogalactoxyloglucans in aerial parts; these high-molecular-weight immunostimulating compounds have low oral bioavailability but may exert effects through gut-associated lymphoid tissue (GALT) and Peyer's patches. • **Glycoproteins:** ~1–2% of dry weight, containing arabinose-rich carbohydrate moieties; contribute to macrophage activation. • **Polyacetylenes:** Including pontica epoxide and other C13 acetylenic compounds at trace levels (~0.001–0.01%); found primarily in roots; some show antifungal and [anti-inflammatory](/ingredients/condition/inflammation) activity. • **Flavonoids:** Rutoside (rutin), quercetin, and kaempferol glycosides present at ~0.1–0.5% of aerial parts; contribute [antioxidant](/ingredients/condition/antioxidant) capacity. • **Essential oil (volatile compounds):** ~0.05–0.3% of aerial parts; contains borneol, bornyl acetate, germacrene D, caryophyllene, and humulene. • **Minerals (in dried herb):** Potassium ~15–20 mg/g, calcium ~8–12 mg/g, magnesium ~2–4 mg/g, iron ~0.1–0.5 mg/g, zinc ~0.02–0.06 mg/g, selenium trace amounts. • **Vitamins:** Trace amounts of vitamin C (~2–5 mg/100g dried herb), small amounts of B-vitamins; not a significant dietary source. • **Fiber:** Crude fiber ~15–25% of dried aerial parts (not typically relevant as it is consumed as tea or extract, not bulk plant material). • **Protein:** ~10–15% crude protein in dried aerial parts (not consumed in nutritionally relevant quantities). • **Bioavailability notes:** Alkamides are the most pharmacokinetically favorable compounds, detectable in plasma within 20 minutes of oral dosing, with peak levels at ~30–60 minutes. Cichoric acid shows lower systemic bioavailability due to esterase degradation but is partially absorbed intact. Polysaccharides are largely not absorbed systemically but interact with immune cells in the gut mucosa. Ethanolic extracts preferentially concentrate alkamides and caffeic acid derivatives, while aqueous extracts (teas) favor polysaccharides and glycoproteins. Standardized commercial preparations typically guarantee alkamide content (≥0.25 mg/mL) and/or cichoric acid content (≥2.5 mg/mL) for quality assurance.

## Dosage & Preparation

Fluid extract: 4 mL twice daily has been studied. The major prophylaxis trial used Echinaforce extract over 4 months, though specific dosing was not provided in available abstracts. Products vary widely in standardization and plant parts used. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Echinacea is generally well-tolerated with mild gastrointestinal upset being the most common side effect. It may interact with immunosuppressive medications like cyclosporine by counteracting their effects. Individuals with autoimmune conditions should use caution as echinacea may stimulate immune activity. Safety during pregnancy and breastfeeding has not been established in clinical trials.

## Scientific Research

The largest clinical trial from Cardiff University involved 755 screened subjects (673 completed) over 4 months, finding significant therapeutic benefits for cold prevention. A meta-analysis of 9 RCTs (1,518 treatment participants) found Echinacea purpurea reduced URTI duration, incidence, and antibiotic usage in children. However, acute treatment studies showed no significant benefit over placebo.

## Historical & Cultural Context

The research dossier does not provide information on the traditional or historical use of Echinacea purpurea. Additional sources would be needed to document its traditional medicine applications.

## Synergistic Combinations

Vitamin C, Zinc, Elderberry, Astragalus, Vitamin D3

## Frequently Asked Questions

### How much echinacea should I take for cold prevention?

Clinical studies typically used 300-500mg of standardized echinacea extract containing 4% phenolics, taken 2-3 times daily. Most preventive trials administered echinacea for 8-12 weeks during cold season.

### Can I take echinacea with other medications?

Echinacea may interact with immunosuppressive drugs like cyclosporine and methotrexate by stimulating immune function. It may also affect liver enzymes that metabolize certain medications, so consult your healthcare provider before combining with prescription drugs.

### How long does it take for echinacea to work?

For prevention, echinacea requires consistent daily use for several weeks to build immune support. When taken at first signs of illness, benefits may be noticed within 24-48 hours, with studies showing reduced symptom duration by an average of 1.4 days.

### Is echinacea safe for children?

Clinical trials have safely used echinacea in children as young as 2 years old, showing significant reduction in respiratory infection duration. However, pediatric dosing should be weight-based and supervised by a healthcare provider.

### What's the difference between echinacea species?

Echinacea purpurea contains higher levels of phenolic compounds and is most studied for immune support. E. angustifolia has more alkylamides but less clinical research, while E. pallida contains different polysaccharide profiles with varying bioactivity.

### What does the research show about echinacea's effectiveness for shortening colds?

Clinical evidence demonstrates that echinacea purpurea significantly reduces the duration of upper respiratory infections, particularly in children, with a moderate effect size (SMD = -0.19) across multiple randomized controlled trials. When used preventively, echinacea may reduce the incidence of respiratory infections by approximately 19%, making it one of the better-studied herbal interventions for cold management. The strongest evidence supports using echinacea as early as possible when infection symptoms first appear rather than relying solely on prevention.

### Can echinacea help reduce the need for antibiotics in respiratory infections?

Research shows that echinacea supplementation reduces antibiotic usage for respiratory infections by approximately 82% in children (RR = 0.18), suggesting it may help the body manage infections without requiring pharmacological intervention. This reduction in antibiotic use is particularly valuable given growing concerns about antibiotic resistance and unnecessary prescribing in pediatric populations. However, echinacea should complement, not replace, medical evaluation for serious or persistent infections.

### Who benefits most from taking echinacea supplements?

Children experiencing recurrent upper respiratory infections appear to benefit most from echinacea, as studies show both reduced infection duration and significantly decreased antibiotic usage in this population. Adults seeking preventive support during cold and flu season may also benefit from the modest 19% reduction in infection incidence documented in meta-analyses. Those with a family history of frequent respiratory infections or immunocompromised individuals (under medical supervision) may find echinacea particularly useful as part of a comprehensive wellness strategy.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*